These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


161 related items for PubMed ID: 2164389

  • 1. Isolation of serotype 2 Marek's disease virus from birds belonging to genus Gallus in Japan.
    Lin JA, Kitagawa H, Ono M, Iwanaga R, Kodama H, Mikami T.
    Avian Dis; 1990; 34(2):336-44. PubMed ID: 2164389
    [Abstract] [Full Text] [Related]

  • 2. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
    Witter RL, Bacon LD, Calvert JG.
    Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
    [Abstract] [Full Text] [Related]

  • 3. Serological characteristics of a membrane glycoprotein gp82 of Marek's disease virus.
    Wu P, Lee LF, Reed WM.
    Avian Dis; 1997; 41(4):824-31. PubMed ID: 9454915
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens.
    Lee LF, Liu X, Witter RL.
    J Immunol; 1983 Feb; 130(2):1003-6. PubMed ID: 6184394
    [Abstract] [Full Text] [Related]

  • 5. Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine.
    Zhang Y, Sharma JM.
    Avian Dis; 2001 Feb; 45(3):639-45. PubMed ID: 11569737
    [Abstract] [Full Text] [Related]

  • 6. A simple immunoperoxidase plaque assay to detect and quantitate Marek's disease virus plaques.
    Silva RF, Calvert JG, Lee LF.
    Avian Dis; 1997 Feb; 41(3):528-34. PubMed ID: 9356696
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H, Quanz S, Suurland B, Spijkers IE, Rodenberg J, Davelaar FG, Jongsma B, Kumar M.
    Vaccine; 2008 Oct 16; 26(44):5595-600. PubMed ID: 18706949
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of a cell line system susceptible to infection with vaccine strains of MDV.
    Abujoub AA, Williams DL, Reilly JD.
    Acta Virol; 1999 Oct 16; 43(2-3):186-91. PubMed ID: 10696443
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of native chicken interferon on MDV replication.
    Levy AM, Heller ED, Leitner G, Davidson I.
    Acta Virol; 1999 Oct 16; 43(2-3):121-7. PubMed ID: 10696431
    [Abstract] [Full Text] [Related]

  • 20. A mass spectrometry-based proteomic approach to study Marek's Disease Virus gene expression.
    Liu HC, Soderblom EJ, Goshe MB.
    J Virol Methods; 2006 Jul 16; 135(1):66-75. PubMed ID: 16563527
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.